The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Purealidin A ID: ALA204484
PubChem CID: 6399281
Max Phase: Preclinical
Molecular Formula: C17H22Br2N6O3
Molecular Weight: 518.21
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: NCCCOc1c(Br)cc(C/C(=N/O)C(=O)NCCc2c[nH]c(N)n2)cc1Br
Standard InChI: InChI=1S/C17H22Br2N6O3/c18-12-6-10(7-13(19)15(12)28-5-1-3-20)8-14(25-27)16(26)22-4-2-11-9-23-17(21)24-11/h6-7,9,27H,1-5,8,20H2,(H,22,26)(H3,21,23,24)/b25-14-
Standard InChI Key: VZDKEGKTDBWXJY-QFEZKATASA-N
Molfile:
RDKit 2D
28 29 0 0 0 0 0 0 0 0999 V2000
1.8444 -22.5500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8432 -23.3773 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5581 -23.7902 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2745 -23.3769 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2716 -22.5463 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5563 -22.1372 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5538 -21.3122 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
1.1284 -23.7893 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
1.1298 -22.1376 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.4155 -22.5503 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2991 -22.1380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0135 -22.5506 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7281 -22.1383 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.9896 -23.7882 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7034 -23.3746 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4186 -23.7860 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7021 -22.5496 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.4160 -22.1360 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.1324 -23.3724 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.4199 -24.6110 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.8475 -23.7837 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5613 -23.3701 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2764 -23.7815 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1679 -24.7792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.5797 -24.0677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0189 -23.4453 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.3608 -24.6009 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4002 -23.9817 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4 14 1 0
6 7 1 0
14 15 1 0
3 4 2 0
15 16 1 0
2 8 1 0
15 17 2 0
17 18 1 0
1 9 1 0
16 19 1 0
4 5 1 0
16 20 2 0
9 10 1 0
19 21 1 0
2 3 1 0
21 22 1 0
10 11 1 0
22 23 1 0
5 6 2 0
11 12 1 0
6 1 1 0
12 13 1 0
24 25 1 0
25 26 2 0
26 23 1 0
23 27 2 0
27 24 1 0
1 2 2 0
25 28 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 518.21Molecular Weight (Monoisotopic): 516.0120AlogP: 1.98#Rotatable Bonds: 10Polar Surface Area: 151.64Molecular Species: BASEHBA: 7HBD: 5#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 7#RO5 Violations (Lipinski): 2CX Acidic pKa: 8.26CX Basic pKa: 9.95CX LogP: 0.47CX LogD: -1.53Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.14Np Likeness Score: 0.32
References 1. Zhu G, Yang F, Balachandran R, Höök P, Vallee RB, Curran DP, Day BW.. (2006) Synthesis and biological evaluation of purealin and analogues as cytoplasmic dynein heavy chain inhibitors., 49 (6): [PMID:16539395 ] [10.1021/jm051030l ]